As digital tools and electronic records become more prevalent in GxP-regulated environments, regulatory bodies are increasingly focusing on cybersecurity.
The FDA and EMA have both introduced new guidelines to ensure the security of electronic data used in GxP environments.
Key Changes:
• Data Protection: Companies must now implement robust cybersecurity measures to protect sensitive patient and production data, including encryption, access controls, and secure cloud storage.
• Incident Reporting: Regulations now require faster reporting of cybersecurity incidents that could impact product safety, data integrity, or public health.
Companies using electronic records, digital monitoring tools, or cloud-based systems in GxP environments must invest in stronger cybersecurity practices to protect their data and ensure compliance with the new regulations.
